Proposed Data Collection Submitted for Public Comment and Recommendations, 2921-2923 [2023-00808]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
2921
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
...........................................................
........................
........................
........................
Type of respondents
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–00809 Filed 1–17–23; 8:45 am]
BILLING CODE 4163–18–P
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2023–00783 Filed 1–17–23; 8:45 am]
BILLING CODE 4163–18–P
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 1009(d) of 5
U.S.C. 10, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 117–286. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–TS–23–001: Identify and Evaluate
Potential Risk Factors for Amyotrophic
Lateral Sclerosis (ALS).
Date: March 21, 2023.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer,
National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia
30341; Telephone: (770) 488–1504;
Email: CGentles@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23BX; Docket No. CDC–2022–
0144]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to take this opportunity to
comment on a proposed information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on a new proposed
information collection project titled PreShift Lighting Interventions to Improve
Miner Safety and Well-Being. The
purpose of this information collection is
to examine the effect of human centric
lighting (HCL) interventions on
circadian disruption (CD) and wellbeing in underground mineworkers.
DATES: Written comments must be
received on or before March 20, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0144 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Total burden
(in hours)
250
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\18JAN1.SGM
18JAN1
2922
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Pre-shift Lighting Interventions to
Improve Miner Safety and Well-being—
New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
lotter on DSK11XQN23PROD with NOTICES1
The National Institute for
Occupational Safety and Health
(NIOSH) seeks a two-year approval from
the Office of Management and Budget
(OBM) to collect information needed to
develop strategies and guidance to
improve the safety, health, and wellbeing of underground shift workers in
the U.S. mining industry. Light has both
visual and non-visual impacts on the
human body, enabling us to visually
perceive the world and non-visually
experience circadian entrainment and
acute effects that include alertness,
concentration, and performance on
cognitive tasks. Hence, light drives our
fundamental physiological functioning.
It is not surprising that underground
miners have significant reductions in
exposure to daylight—especially those
miners working shifts. This lack of
exposure to daylight can lead to fatigue
and circadian disruption (CD) that can
result in sleep loss and reduced
alertness. These factors can increase risk
of accidents and lead to health problems
that include obesity, diabetes, and
cancer.
This study will evaluate the impacts
of blue and red-light treatment at the
beginning of the work shift on reaction
time task performance, sleepiness and
alertness, subjective well-being, sleep
efficiency and circadian rhythms in
underground mine workers.
A 2 x 2 randomized crossover, mixed
design will be used to test the efficacy
and acceptability a human centric
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
lighting (HCL) intervention using lightemitting eyewear delivered to shift
workers at multiple mines within a twoyear study period. A cross-over design
has a significant advantage because the
subjects serve as their own control,
which serves to minimize variations
caused by circadian phase differences,
sleep patterns, etc. of the individual
participants. The other advantages
include greater sample size efficiency
with randomization of treatment order
and all subjects receive all the
treatments. Participants will be
underground miners who regularly
work the 1st, 2nd or 3rd shifts.
NIOSH researchers will obtain
informed consent from volunteer
mineworkers to conduct an intervention
study and administer both electronic
and paper and pencil surveys. Before
beginning the study, the respondents
will provide their informed consent to
participate, be given an overview of the
demographic information that will be
collected and will be instructed how to
properly wear the lighted eyewear, how
to use the actigraphy device, and how
to use a wearable temperature sensor
device. During the course of the study,
participants will be asked to complete
eight short surveys: (1) demographic
information; (2) the Checklist of
Individual Strengths; (3) the Karolinska
Sleepiness Scale (KSS); (4) PROMIS
Sleep Related Impairment
Questionnaire (PSRIQ); (5) PROMIS
Sleep Disturbance Questionnaire
(PSDQ); (6) Shiftwork Disorder
Screening Questionnaire; (7F) the
Lighted Eyeglasses Intervention
Acceptability survey; and (8) MorningEveningness Questionnaire. They will
also be asked to take the NASA
Psychomotor Vigilance Test (PVT), log
caffeine intake and sleep, wear an
actigraphy wristband, and on certain
occasions wear a temperature sensing
device.
Intervention lighting doses will be
administered via commercially available
lightweight, light-emitting glasses
during the nonworking periods or preshift. Each participant will experience
two lighting interventions: Treatment A
is dim red light (10 lx, 3000 K, the
placebo control), and Treatment B is
blue-enriched, polychromatic lighting
(the treatment intervention). For each
study group, half of the subjects will
first experience the blue-light exposure,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
and half will first experience the redlight exposure during a three-week
experimental phase. After a two-week
washout period designed to minimize
carryover or residual learning effects
from the prior treatments, subjects will
experience the lighting treatment
condition they did not yet experience
for another three-week period. While
wearing lighted eyewear the
participants will evaluate comfort, glare
and acceptability of the eyewear, while
the KSS, the PSRIQ, PSDQ, and the
NASA PVT will be re-administered at
various intervals throughout the course
of the study. The total number of
responses for each data collection
instrument are indicated in the
estimated annualized burden hours
table below.
Survey data will be collected during
pre-shift periods and at home on
working days and at home on nonworking days. Time for data collection
at the beginning of the shift will be no
more than 25 minutes. NIOSH
researchers will collect data at
participating sites in above ground
facilities on working days. Participants
will also complete brief caffeine and
sleep logs and wear an actigraphy
wristband that records activity and
sleep patterns and light/dark exposure
while at home. At various intervals of
the study, participants will wear a
temperature sensor device to derive core
body temperature. It is estimated that athome data collection time will be no
more than eight minutes per instance
per participant.
This data collection will occur within
a two-year period beginning after OMB
approval and is designed to gather
information not previously available.
Potential impacts of this project include
improvement of the health, safety, and
well-being of underground mineworkers
by reducing fatigue and CD through new
recommendations and HCLinterventions. This project will also
answer several research questions that
will help establish the efficacy of the
new HCL interventions so that they
could be commercialized by mine
lighting companies and used by
underground mining companies.
CDC requests OMB approval for an
estimated 1,007 annualized burden
hours. There are no costs to respondents
other than their time to participate.
E:\FR\FM\18JAN1.SGM
18JAN1
2923
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Underground
Underground
Underground
Underground
Underground
Underground
Underground
Mineworkers
Mineworkers
Mineworkers
Mineworkers
Mineworkers
Mineworkers
Mineworkers
................
................
................
................
................
................
................
Average
burden per
response
(in hours)
Total
burden
(in hours)
90
90
90
90
90
90
90
1
1
1
1
36
2
2
30/60
30/60
1/60
2/60
1/60
2/60
1/60
45
45
2
3
54
6
3
90
4
10/60
60
90
4
5/60
30
90
90
90
90
90
36
1
49
49
12
6/60
8/60
3/60
1/60
3/60
324
12
221
74
54
Underground Mineworkers ................
Informed consent .............................
Participant Training ..........................
Demographics ..................................
Checklist of Individual Strengths ......
Karolinska Sleepiness Scale ............
Lighted Eyewear ..............................
Lighted Eyeglasses Intervention Acceptability Survey.
PROMIS Sleep Related Impairment
Questionnaire.
PROMIS Sleep Disturbance Questionnaire.
Psychomotor Vigilance Test ............
Shiftwork Disorder Screening ..........
Actigraphy Don and Remove ...........
Caffeine log ......................................
Temperature Sensor Device (on and
remove).
Sleep Log .........................................
90
49
1/60
74
Total ...........................................
...........................................................
........................
........................
........................
1,007
Underground Mineworkers ................
Underground Mineworkers ................
Underground
Underground
Underground
Underground
Underground
Mineworkers
Mineworkers
Mineworkers
Mineworkers
Mineworkers
................
................
................
................
................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–00808 Filed 1–17–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2023–0005; NIOSH 248–
J]
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with provisions
of Title 5 U.S.C. 10, the Centers for
Disease Control and Prevention (CDC)
announces the following meeting for the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC). This
virtual meeting is open to the public.
Time will be available for public
comment.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of
respondents
Form name
The meeting will be held on
February 9, 2023, from 11:00 a.m. to
4:30 p.m., EST. Written public
comments must be received by February
9, 2023. Written comments received
DATES:
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
prior to the meeting will be part of the
official record of the meeting. Members
of the public who wish to address the
WTCHP–STAC during the oral public
comment session must sign up to speak
by February 3, 2023, at the email
address provided in the Procedure for
Oral Public Comment section below.
ADDRESSES: This is a virtual meeting
conducted via Zoom. The public is
welcome to follow the proceedings via
live webcast at the following link:
https://www.ustream.tv/channel/
QyXBRzYjVCS. No registration is
required. For additional information,
please visit the World Trade Center
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified
by Docket No. CDC–2023–0005; NIOSH
248–J by either of the following
methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2023–0005; NIOSH 248–J.
Instructions: All submissions received
must include the Agency name and
Docket Number (CDC–2023–0005;
NIOSH 248–J). The docket will close on
February 9, 2023. All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027; Telephone: (513)
841–4515; Email: wtc-stac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center
(WTC) Health Program, including the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC), was
established by Title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347
(January 2, 2011), as amended by Public
Law 114–113 (December 18, 2015) and
Public Law 116–59 (September 27,
2019), adding Title XXXIII to the Public
Health Service (PHS) Act (codified at 42
U.S.C. 300mm to 300mm-61). All
references to the Administrator in this
document mean the Director of the
National Institute for Occupational
Safety and Health (NIOSH), within the
Centers for Disease Control and
Prevention (CDC), or his or her
designee.
Purpose: The purpose of the WTCHP–
STAC is to review scientific and
medical evidence and to make
recommendations to the Administrator
of the WTC Health Program regarding
additional WTC Health Program
eligibility criteria, potential additions to
the List of WTC-Related Health
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Pages 2921-2923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00808]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-23BX; Docket No. CDC-2022-0144]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies to take this opportunity to comment on a proposed
information collection, as required by the Paperwork Reduction Act of
1995. This notice invites comment on a new proposed information
collection project titled Pre-Shift Lighting Interventions to Improve
Miner Safety and Well-Being. The purpose of this information collection
is to examine the effect of human centric lighting (HCL) interventions
on circadian disruption (CD) and well-being in underground mineworkers.
DATES: Written comments must be received on or before March 20, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0144 by any of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
[[Page 2922]]
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Pre-shift Lighting Interventions to Improve Miner Safety and Well-
being--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National Institute for Occupational Safety and Health (NIOSH)
seeks a two-year approval from the Office of Management and Budget
(OBM) to collect information needed to develop strategies and guidance
to improve the safety, health, and well-being of underground shift
workers in the U.S. mining industry. Light has both visual and non-
visual impacts on the human body, enabling us to visually perceive the
world and non-visually experience circadian entrainment and acute
effects that include alertness, concentration, and performance on
cognitive tasks. Hence, light drives our fundamental physiological
functioning.
It is not surprising that underground miners have significant
reductions in exposure to daylight--especially those miners working
shifts. This lack of exposure to daylight can lead to fatigue and
circadian disruption (CD) that can result in sleep loss and reduced
alertness. These factors can increase risk of accidents and lead to
health problems that include obesity, diabetes, and cancer.
This study will evaluate the impacts of blue and red-light
treatment at the beginning of the work shift on reaction time task
performance, sleepiness and alertness, subjective well-being, sleep
efficiency and circadian rhythms in underground mine workers.
A 2 x 2 randomized crossover, mixed design will be used to test the
efficacy and acceptability a human centric lighting (HCL) intervention
using light-emitting eyewear delivered to shift workers at multiple
mines within a two-year study period. A cross-over design has a
significant advantage because the subjects serve as their own control,
which serves to minimize variations caused by circadian phase
differences, sleep patterns, etc. of the individual participants. The
other advantages include greater sample size efficiency with
randomization of treatment order and all subjects receive all the
treatments. Participants will be underground miners who regularly work
the 1st, 2nd or 3rd shifts.
NIOSH researchers will obtain informed consent from volunteer
mineworkers to conduct an intervention study and administer both
electronic and paper and pencil surveys. Before beginning the study,
the respondents will provide their informed consent to participate, be
given an overview of the demographic information that will be collected
and will be instructed how to properly wear the lighted eyewear, how to
use the actigraphy device, and how to use a wearable temperature sensor
device. During the course of the study, participants will be asked to
complete eight short surveys: (1) demographic information; (2) the
Checklist of Individual Strengths; (3) the Karolinska Sleepiness Scale
(KSS); (4) PROMIS Sleep Related Impairment Questionnaire (PSRIQ); (5)
PROMIS Sleep Disturbance Questionnaire (PSDQ); (6) Shiftwork Disorder
Screening Questionnaire; (7F) the Lighted Eyeglasses Intervention
Acceptability survey; and (8) Morning-Eveningness Questionnaire. They
will also be asked to take the NASA Psychomotor Vigilance Test (PVT),
log caffeine intake and sleep, wear an actigraphy wristband, and on
certain occasions wear a temperature sensing device.
Intervention lighting doses will be administered via commercially
available lightweight, light-emitting glasses during the nonworking
periods or pre-shift. Each participant will experience two lighting
interventions: Treatment A is dim red light (10 lx, 3000 K, the placebo
control), and Treatment B is blue-enriched, polychromatic lighting (the
treatment intervention). For each study group, half of the subjects
will first experience the blue-light exposure, and half will first
experience the red-light exposure during a three-week experimental
phase. After a two-week washout period designed to minimize carryover
or residual learning effects from the prior treatments, subjects will
experience the lighting treatment condition they did not yet experience
for another three-week period. While wearing lighted eyewear the
participants will evaluate comfort, glare and acceptability of the
eyewear, while the KSS, the PSRIQ, PSDQ, and the NASA PVT will be re-
administered at various intervals throughout the course of the study.
The total number of responses for each data collection instrument are
indicated in the estimated annualized burden hours table below.
Survey data will be collected during pre-shift periods and at home
on working days and at home on non-working days. Time for data
collection at the beginning of the shift will be no more than 25
minutes. NIOSH researchers will collect data at participating sites in
above ground facilities on working days. Participants will also
complete brief caffeine and sleep logs and wear an actigraphy wristband
that records activity and sleep patterns and light/dark exposure while
at home. At various intervals of the study, participants will wear a
temperature sensor device to derive core body temperature. It is
estimated that at-home data collection time will be no more than eight
minutes per instance per participant.
This data collection will occur within a two-year period beginning
after OMB approval and is designed to gather information not previously
available. Potential impacts of this project include improvement of the
health, safety, and well-being of underground mineworkers by reducing
fatigue and CD through new recommendations and HCL-interventions. This
project will also answer several research questions that will help
establish the efficacy of the new HCL interventions so that they could
be commercialized by mine lighting companies and used by underground
mining companies.
CDC requests OMB approval for an estimated 1,007 annualized burden
hours. There are no costs to respondents other than their time to
participate.
[[Page 2923]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Underground Mineworkers....... Informed consent 90 1 30/60 45
Underground Mineworkers....... Participant 90 1 30/60 45
Training.
Underground Mineworkers....... Demographics.... 90 1 1/60 2
Underground Mineworkers....... Checklist of 90 1 2/60 3
Individual
Strengths.
Underground Mineworkers....... Karolinska 90 36 1/60 54
Sleepiness
Scale.
Underground Mineworkers....... Lighted Eyewear. 90 2 2/60 6
Underground Mineworkers....... Lighted 90 2 1/60 3
Eyeglasses
Intervention
Acceptability
Survey.
Underground Mineworkers....... PROMIS Sleep 90 4 10/60 60
Related
Impairment
Questionnaire.
Underground Mineworkers....... PROMIS Sleep 90 4 5/60 30
Disturbance
Questionnaire.
Underground Mineworkers....... Psychomotor 90 36 6/60 324
Vigilance Test.
Underground Mineworkers....... Shiftwork 90 1 8/60 12
Disorder
Screening.
Underground Mineworkers....... Actigraphy Don 90 49 3/60 221
and Remove.
Underground Mineworkers....... Caffeine log.... 90 49 1/60 74
Underground Mineworkers....... Temperature 90 12 3/60 54
Sensor Device
(on and remove).
Underground Mineworkers....... Sleep Log....... 90 49 1/60 74
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,007
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-00808 Filed 1-17-23; 8:45 am]
BILLING CODE 4163-18-P
